Christian F Jehn1, Ingo J Diel2, Friedrich Overkamp3, Andreas Kurth4, Reinhold Schaefer5, Kurt Miller6, Diana Lüftner7. 1. Department of Hematology, Oncology and Tumor Immunology, University Hospital Charité, Berlin, Germany Christian.Jehn@charite.de. 2. Practice for Medical Oncology and Gynaecology am Rosengarten, Mannheim, Germany. 3. Practice for Medical Oncology, Recklinghausen, Germany. 4. THEMISTOCLES GLUCK Hospital Ratingen, Ratingen, Germany. 5. Practice for Urology Bonn-Rhein-Sieg, Bonn, Germany. 6. Department of Urology, University Hospital Charité, Berlin, Germany. 7. Department of Hematology, Oncology and Tumor Immunology, University Hospital Charité, Berlin, Germany.
Abstract
BACKGROUND: Bone is a frequent site of metastases in advanced cancer and is associated with significant skeletal morbidity. Current treatment options are aimed at preserving and improving functional independence and quality of life. MATERIALS AND METHODS: A review of current literature focusing on diagnostic tools and treatment approaches of bone metastasis in advanced cancer was performed and conclusions were incorporated into diagnostic and treatment algorithms. RESULTS: Radiologic imaging has added valuable tools for screening and diagnostics of bone metastasis. Clinical management of skeletal metastasis includes improved pain management, introduction of bone modifying agents and advancements in surgical and radiation therapy. We propose three algorithms enhancing the sensitivity of diagnostics and improving multidisciplinary management of vertebral and non-vertebral bone metastasis. CONCLUSION: Bone metastases are an expression of a systemic disease. Treatment options include highly specialized modalities yet need to be tailored to individual needs. Algorithms help standardize treatment procedures and can improve treatment outcome in a multidisciplinary setting. Copyright
BACKGROUND: Bone is a frequent site of metastases in advanced cancer and is associated with significant skeletal morbidity. Current treatment options are aimed at preserving and improving functional independence and quality of life. MATERIALS AND METHODS: A review of current literature focusing on diagnostic tools and treatment approaches of bone metastasis in advanced cancer was performed and conclusions were incorporated into diagnostic and treatment algorithms. RESULTS: Radiologic imaging has added valuable tools for screening and diagnostics of bone metastasis. Clinical management of skeletal metastasis includes improved pain management, introduction of bone modifying agents and advancements in surgical and radiation therapy. We propose three algorithms enhancing the sensitivity of diagnostics and improving multidisciplinary management of vertebral and non-vertebral bone metastasis. CONCLUSION: Bone metastases are an expression of a systemic disease. Treatment options include highly specialized modalities yet need to be tailored to individual needs. Algorithms help standardize treatment procedures and can improve treatment outcome in a multidisciplinary setting. Copyright
Keywords:
Metastatic bone disease; algorithm for diagnostic and treatment; bone-targeted agents; multidisciplinary management; non-vertebral bone metastasis; review; skeletal morbidity; vertebral bone metastasis
Authors: Caroline A Burgard; Julien Dinkel; Frederik Strobl; Philipp M Paprottka; Nicolai Schramm; Maximilian Reiser; Christoph G Trumm Journal: Diagn Interv Radiol Date: 2018 May-Jun Impact factor: 2.630
Authors: Antonio Jose Martin-Perez; María Fernández-González; Paula Postigo-Martin; Marc Sampedro Pilegaard; Carolina Fernández-Lao; Eduardo Castro-Martín; Lydia Martín-Martín; Mario Lozano-Lozano Journal: Int J Environ Res Public Health Date: 2021-04-10 Impact factor: 3.390
Authors: Sarah Danson; Matthew R Mulvey; Lesley Turner; Janet Horsman; KJane Escott; Robert E Coleman; Sam H Ahmedzai; Michael I Bennett; David Andrew Journal: J Bone Oncol Date: 2019-09-18 Impact factor: 4.072
Authors: A Nervo; A Ragni; F Retta; M Gallo; A Piovesan; V Liberini; M Gatti; U Ricardi; D Deandreis; E Arvat Journal: J Endocrinol Invest Date: 2020-08-03 Impact factor: 4.256